- Home
- WTRG vs KRYS Comparison
WTRG vs KRYS Comparison
Compare WTRG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTRG | KRYS |
|---|---|---|
| Founded | 1901 | 2015 |
| Country | United States | United States |
| Employees | 1615 | N/A |
| Industry | Water Supply | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.3B |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | WTRG | KRYS |
|---|---|---|
| Price | $39.67 | $354.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $43.50 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 2.1M | 333.5K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | 1.38 | ★ 128.00 |
| EPS | 0.79 | ★ 1.83 |
| Revenue | ★ $2,474,615,000.00 | $389,130,000.00 |
| Revenue This Year | $5.07 | $38.74 |
| Revenue Next Year | $7.31 | $32.53 |
| P/E Ratio | ★ $49.99 | $186.03 |
| Revenue Growth | 18.62 | ★ 33.94 |
| 52 Week Low | $36.11 | $130.50 |
| 52 Week High | $42.37 | $382.54 |
Technical Indicators
Market Signals| Indicator | WTRG | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 53.78 |
| Support Level | $38.12 | $246.17 |
| Resistance Level | $40.37 | $382.33 |
| Average True Range (ATR) | 0.96 | 16.24 |
| MACD | 0.08 | -4.77 |
| Stochastic Oscillator | 68.95 | 50.48 |
Price Performance
Historical ComparisonAbout WTRG Essential Utilities Inc.
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.